摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(diaminomethylideneamino)-N-[3-[[4-[[3-[5-(diaminomethylideneamino)pentanoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]carbamoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]pentanamide | 1613588-93-4

中文名称
——
中文别名
——
英文名称
5-(diaminomethylideneamino)-N-[3-[[4-[[3-[5-(diaminomethylideneamino)pentanoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]carbamoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]pentanamide
英文别名
——
5-(diaminomethylideneamino)-N-[3-[[4-[[3-[5-(diaminomethylideneamino)pentanoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]carbamoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]pentanamide化学式
CAS
1613588-93-4
化学式
C42H56F6N16O4
mdl
——
分子量
963.002
InChiKey
JYDLNBRPIFNKCB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    68
  • 可旋转键数:
    18
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    300
  • 氢给体数:
    12
  • 氢受体数:
    16

反应信息

  • 作为产物:
    描述:
    C72H104F6N16O16盐酸 作用下, 以 1,4-二氧六环 为溶剂, 以20%的产率得到5-(diaminomethylideneamino)-N-[3-[[4-[[3-[5-(diaminomethylideneamino)pentanoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]carbamoylamino]-2-piperazin-1-yl-5-(trifluoromethyl)phenyl]pentanamide
    参考文献:
    名称:
    Hybrid Compounds And Methods Of Making And Using The Same
    摘要:
    本公开提供化合物或其药学上可接受的盐,用于抑制微生物的生长;治疗患有微生物感染、疟疾、粘膜炎、眼部感染、耳部感染、癌症或分枝杆菌感染的哺乳动物;杀灭或抑制疟原虫的生长;抑制分枝杆菌的生长;调节哺乳动物的免疫反应;或对抗非分馏肝素、低分子量肝素或肝素/低分子量肝素衍生物。
    公开号:
    US20140171438A1
点击查看最新优质反应信息

文献信息

  • [EN] HYBRID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS HYBRIDES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:CELLCEUTIX CORP
    公开号:WO2014093231A2
    公开(公告)日:2014-06-19
    The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the gr 5 owth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
  • Hybrid Compounds And Methods Of Making And Using The Same
    申请人:Pan Wenxi
    公开号:US20140171438A1
    公开(公告)日:2014-06-19
    The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
    本公开提供化合物或其药学上可接受的盐,用于抑制微生物的生长;治疗患有微生物感染、疟疾、粘膜炎、眼部感染、耳部感染、癌症或分枝杆菌感染的哺乳动物;杀灭或抑制疟原虫的生长;抑制分枝杆菌的生长;调节哺乳动物的免疫反应;或对抗非分馏肝素、低分子量肝素或肝素/低分子量肝素衍生物。
查看更多